Left ventricular dysfunction in normotensive Type 1 diabetic patients: The impact of autonomic neuropathy

Diabetic Medicine

Volumn 21, Issue 6, 2004, Pages 524-530

  Taskiran, M ^a   Rasmussen, V ^a   Rasmussen, B ^a   Fritz Hansen, T ^a   Larsson, H B W ^a   Jensen, G B ^a   Hilsted, J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Autonomic neuropathy; Cine MRI; Echocardiography; Left ventricular diastolic dysfunction; Systolic function

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS;

AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; CATECHOLAMINES; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2942610467     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01145.x     Document Type: Article

References (45)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
2. Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 1995; 18: 708-714.
3. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977; 60: 884-899.
4. Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 1988; 12: 114-120.
5. Gotzsche O, Darwish A, Gotzsche L, Hansen LP, Sorensen KE. Incipient cardiomyopathy in young insulin-dependent diabetic patients: a seven-year prospective Doppler echocardiographic study. Diabet Med 1996; 13: 834-840.
6. Danielsen R, Nordrehaug JE, Lien E, Vik-Mo H. Subclinical left ventricular abnormalities in young subjects with long-term type 1 diabetes mellitus detected by digitized M-mode echocardiography. Am J Cardiol 1987; 60: 143-146.
7. Lababidi ZA, Goldstein DE. High prevalence of echocardiographic abnormalities in diabetic youths. Diabetes Care 1983; 6: 18-22.
8. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophie cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
9. Monteagudo PT, Moises VA, Kohlmann O, Ribeiro AB, Lima VC, Zanella MT. Influence of autonomie neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin Cardiol 2000; 23: 371-375.
10. Irace L, Iarussi D, Guadagno I, Tedesco MA, Perna B, Ratti G et al. Left ventricular performance and autonomic dysfunction in patients with long-term insulin-dependent diabetes mellitus. Acta Diabetol 1996; 33: 269-273.
11. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999; 7: 342-357.
12. Karavanaki K, Baum JD. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003; 16: 79-90.
13. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomie nervous system testing. Neurology 1992; 42: 1831-1837.
14. Kjaer M, Secher NH, Bach FW, Galbo H. Role of motor center activity for hormonal changes and substrate mobilization in humans. Am J Physiol 1987; 253: R687-R695.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
16. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-270.
17. Kahn JK, Zola B, Juni JE, Vinik AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomie neuropathy. J Am Coll Cardiol 1986; 7: 1303-1309.
18. Regan TJ, Lyons MM. Diabetic cardiomyopathy. Circulation 1991; 83: 1830.
19. Riggs TW, Transue D. Doppler echocardiographic evaluation of left ventricular diastolic function in adolescents with diabetes mellitus. Am J Cardiol 1990; 65: 899-902.
20. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602.
21. Starling MR. Does a clinically definable diabetic cardiomyopathy exist? J Am Coll Cardiol 1990; 15: 1518-1520.
22. Willenheimer RB, Erhardt LR, Nilsson H, Lilja B, Juul-Moller S, Sundkvist G. Parasympathetic neuropathy associated with left ventricular diastolic dysfunction in patients with insulin-dependent diabetes mellitus. Scand Cardiovasc J 1998; 32: 17-22.
23. Zola B, Kahn JK, Juni JE, Vinik AI. Abnormal cardiac function in diabetic patients with autonomie neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab 1986; 63: 208-214.
24. Airaksinen J, Ikaheimo M, Kaila J, Linnaluoto M, Takkunen J. Impaired left ventricular filling in young female diabetics. An echocardiographic study. Acta Med Scand 1984; 216: 509-516.
25. Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol 1989; 64: 1010-1016.
26. Shapiro LM, Howat AP, Calter MM. Left ventricular function in diabetes mellitus. I. Methodology, and prevalence and spectrum of abnormalities. Br Heart J 1981; 45: 122-128.
27. Shapiro LM, Leatherdale BA, Mackinnon J, Fletcher RF. Left ventricular function in diabetes mellitus. II. Relation between clinical features and left ventricular function. Br Heart J 1981; 45: 129-132.
28. Shapiro LM. Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J 1982; 47: 439-444.
29. Hilsted J, Galbo H, Christensen NJ, Parving HH, Benn J. Haemodynamic changes during graded exercise in patients with diabetic autonomie neuropathy. Diabetologia 1982; 22: 318-323.
30. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994; 8: 65-73.
31. Uusitupa MI, Mustonen JN, Airaksinen KE. Diabetic heart muscle disease. Ann Med 1990; 22: 377-386.
32. Vanninen E, Mustonen J, Vainio P, Lansimies E, Uusitupa M. Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am J Cardiol 1992; 70: 371-378.
33. Sato A, Tarnow L, Parving HH. Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy. Diabetes Care 1998; 21: 1534-1539.
34. Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsrtz R, Howard BV et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001; 37: 1943-1949.
35. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 1983; 72: 732-738.
36. Simpson P. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ Res 1985; 56: 884-894.
37. Rapacciuolo A, Esposito G, Caron K, Mao L, Thomas SA, Rockman HA. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J Am Coll Cardiol 2001; 38: 876-882.
38. Laks MM, Morady F, Swan HJ. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 1973; 64: 75-78.
39. King BD, Sack D, Kichuk MR, Hintze TH. Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs. Hypertension 1987; 9: 582-590.
40. Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens 2001; 15: 239-246.
41. Johnson EM Jr, Manning PT. Guanethidine-induced destruction of sympathetic neurons. Int Rev Neurobiol 1984; 25: 1-37.
42. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension 1997; 30: 1062-1067.
43. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 1981; 68: 1427-1434.
44. Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D et al. Sympathetically mediated hypertension in autonomic failure. Circulation 2000; 101: 2710-2715.
45. Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000; 355: 725-726.